Serum biomarker profiles were also studied, and the results showed that inflammatory biomarkers increased, especially the levels of IL-5, IL-1β, IL-7, IL-1R1, and IL-15 in the serum of patients with AD, which also supported the idea that AD was a systemic disease (73). The gene discussed is IL5; the disease is Alzheimer disease.